News

China NMPA accepts CARsgen Therapeutics’ NDA for satri-cel to treat Claudin18.2-positive advanced G/GEJA: Shanghai, China Friday, June 27, 2025, 12:00 Hrs [IST] CARsgen Therapeu ...
Recordati signs licensing agreement with Amarin to commercialize cardiovascular medicine, Vazkepa in Europe: Milan, Italy Friday, June 27, 2025, 11:00 Hrs [IST] Recordati, an inte ...
Pfizer announces positive results from phase 3 BASIS study of Hympavzi in haemophilia A or B with inhibitors: New York Friday, June 27, 2025, 10:00 Hrs [IST] Pfizer Inc. announced ...
Gap between domestic GMP & GMP required for intl compliance is huge: Dr Amaresh Tumbagi: Nandita Vijayasimha, Bengaluru Friday, June 27, 2025, 08:00 Hrs [IST] Drug regulators have ...
Pharmac South expands to 175+ stalls, expected to attract 15,000 visitors: Peethaambaran Kunnathoor, Chennai Friday, June 27, 2025, 08:00 Hrs [IST] The upcoming 10 ...
DCC agrees with DTAB proposal to fix QR codes on vaccines, antimicrobials, anticancer & NDPS drugs: Gireesh Babu, New Delhi Friday, June 27, 2025, 08:00 Hrs [IST] The Drugs Consul ...
NABH announces initiation process for its 3-day Assessors’ Training Programme for entry level hospitals: Shardul Nautiyal, Mumbai Friday, June 27, 2025, 08:00 Hrs [IST] The Nati ...
Karnataka govt on a 3-year mission for advanced healthcare access: Nandita Vijayasimha, Bengaluru Friday, June 27, 2025, 08:00 Hrs [IST] The Karnataka government is ramping up eff ...
Aspire Biopharma enrolls last patient in phase 1 trial of its oral transmucosal fast-acting high-dose aspirin formulation: Estero, Florida Thursday, June 26, 2025, 18:00 Hrs [IST] ...
Kashmik Formulation to expand capacity, eyes Rs. 100 crore revenue in FY26: Our Bureau, Mumbai Thursday, June 26, 2025, 17:50 Hrs [IST] Kashmik Formulation, a pharmaceutical manuf ...
Despite increased scrutiny, Indian exports to US to maintain growth trajectory, says CareEdge Ratings: Our Bureau, New Delhi Thursday, June 26, 2025, 17:20 Hrs [IST] Even as the I ...
START Center for Cancer Research introduces a new digital patient & physician-focused platform for community-based cancer trials: San Antonio, Texas Thursday, June 26, 2025, 17:00 ...